Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (2205)	2/6/2000 3:45:00 PM
From: Carl R.	Read Replies (1) \| Respond to of 5582

Yes Hank, your point is valid that not all of the viruses will be equally susceptible to the same treatment. If pleconaril is now effective against 96% of them, it also shows that there can be treatments that are effective against most of them. Thus we are at a theoretical impasse that can not be resolved without more research. I would expect that additional scientific research will be conducted in the area, and in the meantime non-scientific research will be conducted on themselves by the buyers of Zicam. It will be interesting to see if they are sufficiently satisfied to become repeat purchasers. Carl